CLL Society Educational Forums
Friday, October 15, 2021 at 11:00 AM PT, 12:00 PM MT, 1:00 PM CT, 2:00 PM ET
Join us for CLL Society’s Ed Forum: The Right Tests at the Right Time to learn the basics about testing across the span of your CLL journey. Dr. Ryan Jacobs will discuss at the time of diagnosis, which tests should be performed, which might be avoided, and why. Dr. Brian Hill will discuss before starting your first treatment, and prior to every subsequent treatment, know which tests you absolutely must have, which we strongly advise through CLL Society’s Test Before Treat™ campaign. Two patients will share their stories about the importance of getting the right tests completed prior to choosing treatment. Finally, learn how CLL is monitored over time, and how the evolving role of MRD (measurable residual disease) testing may help determine when to stop therapy in CLL. Learn more and register here.
Tuesday, November 9, 2021 at 5:00 – 7:00 PM MT
In partnership with Huntsman Cancer Institute (HCI), CLL Society invites you to attend our virtual 5th Annual Patient & Caregiver Ed Forum focused on chronic lymphocytic leukemia (CLL). Featured speakers will present the basics of CLL diagnosis, early management, clinical trials, treatment options, COVID-19 considerations for CLL patients, patient perspectives, and strategies to become an effective self-advocate. Learn more and register here.
On April 21, 2021 CLL Society presented CAR-T Ed Forum: The Basic Science and Latest Data . Dr. John Pagel will bring the beginner up to pace with what CAR-T therapy is, how it works and where the science is leading. Dr. Tanya Siddiqi will present current data on the success of CAR-T therapy CLL, with and without ibrutinib. Dr. Larry and Sharon Saltzman will share their CLL CAR-T journey from the doctor-turned-patient and caregiver’s points of view. View this event On Demand here!
On Feb. 4, CLL Society hosted ASH 2020 Comes to You! Dr. Anthony Mato discussed LOXO-305, updates from the inform CLL Registry, which confirms CLL Society’s Test Before Treat™ campaign, the impact of del(17p) survival of CLL patients with ibrutinib frontline, and a one-pill triple combination targeting Richter Transformation. Dr. William Wierda discussed the TRANSCEND Study: Liso-cel (JCAR017) in combination with ibrutinib, as well as present data from the MRD Cohort of the CAPTIVATE Study. View this event On Demand here!
On Nov. 17, CLL Society Virtual Patient & Caregiver Educational Forum with Dr. Deborah Stephens at Huntsman Cancer Institute was a great learning experience for all. In both her research and her clinical practice, Dr. Stephens is known to be particularly sensitive to the issues that are of importance to patients during their CLL journey. Our Instant Replay of Dr. Stephens and her team at Huntsman, partnering with CLL Society again this year to host a well-rounded joint effort to cover the basics of CLL diagnosis, early management, clinical trials, treatment options and patient perspectives. View the Ed Forum On Demand HERE!
CLL Society hosted a Global Virtual Patient & Caregiver Educational Forum on Saturday, October 10 with faculty from across the country. Can’t miss topics from CLL experts will include early management in CLL, Test Before Treat, frontline therapy options, measuring response, clinical trials, CAR-T, vaccines, Richter’s Transformation, and more! Also patients and caregivers spoke about being your own advocate and the value of joining support groups. View the Ed Forum On Demand HERE!